89 related articles for article (PubMed ID: 9050812)
1. Systemic delivery of melanotan II through the ocular route in rabbits.
Pinsuwan S; Myrdal PB; Yalkowsky SH
J Pharm Sci; 1997 Mar; 86(3):396-7. PubMed ID: 9050812
[No Abstract] [Full Text] [Related]
2. Determination of melanotan II in rabbit urine using solid-phase extraction sample preparation followed by reversed-phase high-performance liquid chromatography.
Walters AE; Myrdal PB; Pinsuwan S; Manka AM; Yalkowsky SH
J Chromatogr B Biomed Sci Appl; 1997 Mar; 690(1-2):99-103. PubMed ID: 9106033
[TBL] [Abstract][Full Text] [Related]
3. Preformulation studies with melanotan-II: a potential skin cancer chemopreventive peptide.
Lan EL; Ugwu SO; Blanchard J; Fang X; Hruby VJ; Sharma S
J Pharm Sci; 1994 Aug; 83(8):1081-4. PubMed ID: 7983590
[TBL] [Abstract][Full Text] [Related]
4. Use of melanotan I and II in the general population.
Evans-Brown M; Dawson RT; Chandler M; McVeigh J
BMJ; 2009 Feb; 338():b566. PubMed ID: 19224885
[No Abstract] [Full Text] [Related]
5. Melanotan and the posterior reversible encephalopathy syndrome.
Kaski D; Stafford N; Mehta A; Jenkins IH; Malhotra P
Ann Intern Med; 2013 May; 158(9):707-8. PubMed ID: 23648958
[No Abstract] [Full Text] [Related]
6. Melanotan-II: Investigation of the inducer and facilitator effects on penile erection in anaesthetized rat.
Giuliano F; Clément P; Droupy S; Alexandre L; Bernabé J
Neuroscience; 2006; 138(1):293-301. PubMed ID: 16360286
[TBL] [Abstract][Full Text] [Related]
7. Determination of melanotan-II in rat plasma by liquid chromatography/tandem mass spectrometry: determination of pharmacokinetic parameters in rat following intravenous administration.
Mock S; Shen X; Tamvakopoulos C
Rapid Commun Mass Spectrom; 2002; 16(22):2142-7. PubMed ID: 12415547
[TBL] [Abstract][Full Text] [Related]
8. A glimpse into the underground market of melanotan.
Callaghan Iii DJ
Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142729
[TBL] [Abstract][Full Text] [Related]
9. Eruptive naevi and darkening of pre-existing naevi 24 h after a single mono-dose injection of melanotan II.
Schulze F; Erdmann H; Hardkop LH; Anemüller W; Rose C; Zillikens D; Fischer TW
Eur J Dermatol; 2014; 24(1):107-9. PubMed ID: 24334249
[No Abstract] [Full Text] [Related]
10. [The Barbie drug melanotan--new internet drug with risky consequences].
Knudsen K; Kjergaard C; Dalhoff K
Lakartidningen; 2012 Oct 17-23; 109(42):1895-6. PubMed ID: 23193937
[No Abstract] [Full Text] [Related]
11. Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.
Nelson ME; Bryant SM; Aks SE
Clin Toxicol (Phila); 2012 Dec; 50(10):1169-73. PubMed ID: 23121206
[TBL] [Abstract][Full Text] [Related]
12. Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407.
Bhardwaj R; Blanchard J
J Pharm Sci; 1996 Sep; 85(9):915-9. PubMed ID: 8877878
[TBL] [Abstract][Full Text] [Related]
13. Discovery and development of novel melanogenic drugs. Melanotan-I and -II.
Hadley ME; Hruby VJ; Blanchard J; Dorr RT; Levine N; Dawson BV; al-Obeidi F; Sawyer TK
Pharm Biotechnol; 1998; 11():575-95. PubMed ID: 9760697
[No Abstract] [Full Text] [Related]
14. Hemodynamic actions and mechanisms of systemically administered α-MSH analogs in mice.
Rinne P; Tikka S; Mäkelä S; Streng T; Savontaus E
Peptides; 2012 Nov; 38(1):150-8. PubMed ID: 22982611
[TBL] [Abstract][Full Text] [Related]
15. [Melanotan-induced lentigines and nevi].
Thestrup-Pedersen K; Søndergaard K
Ugeskr Laeger; 2011 Mar; 173(13):975. PubMed ID: 21453640
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silicon microparticles as carriers for peptides.
Kilpeläinen M; Mönkäre J; Riikonen J; Vlasova M; Salonen J; Lehto VP; Herzig KH; Järvinen K
J Control Release; 2010 Nov; 148(1):e43-4. PubMed ID: 21529616
[No Abstract] [Full Text] [Related]
17. Systemic delivery of insulin via an enhancer-free ocular device.
Lee YC; Simamora P; Yalkowsky SH
J Pharm Sci; 1997 Dec; 86(12):1361-4. PubMed ID: 9423146
[TBL] [Abstract][Full Text] [Related]
18. Melanoma associated with the use of melanotan-II.
Hjuler KF; Lorentzen HF
Dermatology; 2014; 228(1):34-6. PubMed ID: 24355990
[TBL] [Abstract][Full Text] [Related]
19. Discovery that a melanocortin regulates sexual functions in male and female humans.
Hadley ME
Peptides; 2005 Oct; 26(10):1687-9. PubMed ID: 15996790
[TBL] [Abstract][Full Text] [Related]
20. Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review.
Habbema L; Halk AB; Neumann M; Bergman W
Int J Dermatol; 2017 Oct; 56(10):975-980. PubMed ID: 28266027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
